Showing results (111-120 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trialStefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
The Lancet. Haematology|May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trialBenjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.
The Lancet. Haematology|May 28, 2021
Eliminating race-based reference ranges in haematology: a call to actionAngela C Weyand, Patrick T McGann
The Lancet. Haematology|July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Yimei Li, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
The Lancet. Haematology|December 22, 2015
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort studySophie Uyoga, Carolyne M Ndila, Alex W Macharia, et al.
The Lancet. Haematology|December 22, 2015
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trialJun Imagawa, Hideo Tanaka, Masaya Okada, et al.
The Lancet. Haematology|December 22, 2015
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 studyFranck E Nicolini, Gabriel Etienne, Viviane Dubruille, et al.
The Lancet. Haematology|December 22, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle studyPeter Vandenberghe, Iwona Wlodarska, Thomas Tousseyn, et al.
The Lancet. Haematology|December 22, 2015
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysisShaan Chugh, Saeed Darvish-Kazem, Wendy Lim, et al.
Pageof 73